Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-1 of 1
Keywords: fludrocortisone acetate
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Isamu Miyamori, Masatoshi Ikeda, Takao Matsubara, Shinya Okamoto, Hideo Koshida, Toshio Morise, Ryoyu Takeda
Journal:
Clinical Science
Clin Sci (Lond) (1987) 73 (4): 431–436.
Published: 01 October 1987
..., as indicated by an abrupt increase in sodium excretion on the third to sixth day of 9α-fludrocortisone acetate administration (0.6 mg/day), was observed in all subjects. 3. The mean plasma h-αANP level was 30.9 ± sem 8.8 pmol/l on the control day; it increased exponentially in response to 9α-fludrocortisone...
